SignPath Pharma (www.signpathpharma.com) is a clinical stage biotechnology company (Delaware C Corp.) founded in 2006. Currently, SignPath is actively developing products to treat cancer and mitigate drug-induced cardiac arrhythmia, which is a serious and common side effect of many drugs, and heart ...
Use this information to figure out if this company is an ideal customer for you.
215.538.9996
9710 Ruskin Circle
Sandy, 84092
SignPath Pharma Inc.'s CEO is Bruce Meyers
SignPath Pharma Inc.'s CFO is Pete Childs
SignPath Pharma Inc.'s HQ is located at 9710 Ruskin Circle, Sandy
SignPath Pharma Inc.'s phone number is 215.538.9996
SignPath Pharma Inc.'s official website is signpathpharma.com
SignPath Pharma Inc.'s revenue is $1M - $5M
SignPath Pharma Inc. has 51 - 200 employees
SignPath Pharma Inc. is in the industry of: Pharmaceuticals